Medindia

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Oncology Media Relations   Oncology_media_relations@its.jnj.com     Investor contact: Jess Margevich investor-relations@its.jnj.com ...

Olivia Bowen reveals husband Alex has undergone a vasectomy as she could ‘never go through childbirth again’ after ‘nearly dying’ during traumatic delivery of daught…

The Love Island star, 32, shares the six-month-old tot as well as son Abel, three, with with her husband, 34, whom she wed in ...

They Didn’t Want to Have C-Sections. A Judge Would Decide How They Gave Birth.

The post They Didn’t Want to Have C-Sections. A Judge Would Decide How They Gave Birth. appeared first on ProPublica.
News-Medical.Net

Early prenatal shunt treatment improves outcomes for fetal megacystis

An interdisciplinary team from the University Hospitals Cologne and Bonn have conducted the first prospective study to ...
UroToday

EAU 2026: Impact of 89Zr-girentuximab PET Versus Conventional Imaging on Clinical Decision-making in Patients with Indeterminate Renal Masses (ZIRCON-X)

Annual Congress was host to a renal cell carcinoma abstract session. Dr. David Liu presented results from ZIRCON-X, a post-hoc analysis of the phase 3 ZIRCON study evaluating the potential impact of ...
UroToday

EAU 2026: [89Zr]Zr-girentuximab PET/CT in the Non-invasive Characterization of Indeterminate Renal Lesions: Initial Real-world Clinical Experience

Annual Congress was host to a renal cell carcinoma abstract session. Dr. Huebner-Resch presented her team’s initial real-world experience using [89 Zr]Zr-girentuximab PET/CT in the routine evaluation ...